Form 4: Moderna CFO Reports Stock Transaction
Insider Transaction (Form 4)
James M Mock, Chief Financial Officer of Moderna, Inc., reported multiple transactions in common stock on October 5, 2026.
Summary
- Option exercise/conversion: acquired 1,454 Common Stock on October 5, 2026; holds 60,829 after (Direct).
- Tax/exercise-price withholding: disposed of 704 Common Stock at $190.01 ($133,767) on October 5, 2026; holds 60,125 after (Direct).
- Option exercise/conversion: disposed of 1,454 Restricted Stock Units on October 5, 2026 (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
James M Mock — Officer (Chief Financial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-05 | Option exercise/conversion | Common Stock | 1,454 | — | — | 60,829 |
| 2026-10-05 | Tax/exercise-price withholding | Common Stock | 704 | $190 | $133.8K | 60,125 |
| 2026-10-05 | Option exercise/conversion | Restricted Stock Units | 1,454 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-05 | Option exercise/conversion (1,454 shares) |
| 2026-10-05 | Tax/exercise-price withholding (704 shares) |
| 2026-10-05 | Option exercise/conversion (1,454 shares) |
Keywords
insider transaction, Form 4, MRNA, Moderna, Inc., neutral, James M Mock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.